Evidence map›Paper›PMID 29288097›Full record

SynthesisJournal of the American Academy of Dermatology2018

Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review.

Grace Y Kim, Leah A Schmelkin, Mark D P Davis, Rokea A El-Azhary, Ann M Farrell, Alexander Meves, Julia S Lehman

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of the American Academy of Dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Common and critical inflammatory dermatoses every pathologist should know.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Grace Y KimMayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota.
Leah A SchmelkinMayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, Minnesota.
Mark D P DavisDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
Rokea A El-AzharyDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
Ann M FarrellMayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota.
Alexander MevesDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota.
Julia S LehmanDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: lehman.julia@mayo.edu.
Mayo Clinic · USWinnMed · US

Funding

Precision Medicine by Targeting Cell Adhesion in MelanomaK08CA215105 · NCI · MAYO CLINIC ROCHESTER · PI MEVES, ALEXANDER · 2017 to 2021
$854k
NCI NIH HHS K08 CA215105
6 · The paper itself

Abstract

backgroundGraft-versus-host-disease (GVHD) after solid organ transplantation (SOT) is extremely rare.

objectiveTo investigate the dermatologic manifestations and clinical outcomes of SOT GVHD.

methodsSystematic literature review of SOT GVHD.

resultsAfter full-text article review, we included 61 articles, representing 115 patients and 126 transplanted organs. The most commonly transplanted organ was the liver (n = 81). Among 115 patients, 101 (87.8%) developed skin involvement. The eruption appeared an average of 48.3 days (range, 3-243 days) posttransplant and was pruritic in 5 of 101 (4.9%) cases. The eruption was described as morbilliform in 2 patients (1.9%), confluent in 6 (5.9%), and desquamative in 4 (3.9%) cases. In many cases, specific dermatologic descriptions were lacking. The mortality rate was 72.2%. Relative time of death was reported in 23 patients who died during the follow-up period. These patients died an average of 99.2 days (range, 22-270 days) posttransplant, or 50.9 days after the appearance of dermatologic symptoms. Frequent causes of death were sepsis and multiorgan failure. LIMITATIONS: Incomplete descriptions of skin findings and potential publication bias resulting in publication of only the most severe cases.

conclusionsGVHD is a potentially fatal condition that can occur after SOT and often presents with a skin rash. We recommend that dermatologists have a low threshold to consider and pursue this diagnosis in the setting of post-SOT skin eruption.

Indexed as

FemaleGraft RejectionGraft SurvivalGraft vs Host DiseaseHumansKidney TransplantationLiver TransplantationLung TransplantationMaleOrgan TransplantationPrognosisRisk AssessmentSeverity of Illness IndexSkin DiseasesSurvival Analysisdermatopathologygraft-versus-host diseasetransplant

Identifiers

PMID29288097
PMCPMC6167008
OpenAlexW2775846177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.